Last news
Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023

Harbour BioMed Reports Results of Phase Ib Clinical Trial of Porustobart in Combination of Toripalimab in Patients with Hepatocellular Carcinoma at ASCO 2023

...

GreenCo Promotes Early Preparation for Enhanced ESG Disclosures in 2024

GreenCo Promotes Early Preparation for Enhanced ESG Disclosures in 2024

...

NetEase Games Unveils PinCool, Inc., a New Multifunctional Studio Aiming to Produce Global Entertainment Content

NetEase Games Unveils PinCool, Inc., a New Multifunctional Studio Aiming to Produce Global Entertainment Content

...

Veken And ESY SUNHOME Reached A Strategic Cooperation on Sodium Batteries to Jointly Promote the New Development of Energy Storage

Veken And ESY SUNHOME Reached A Strategic Cooperation on Sodium Batteries to Jointly Promote the New Development of Energy Storage

...

TYAN Server Platforms to Boost Data Center Computing Performance with 4th Gen AMD EPYC Processors at Computex 2023

TYAN Server Platforms to Boost Data Center Computing Performance with 4th Gen AMD EPYC Processors at Computex 2023

...

SparkLabs Cultiv8 launches CleanTech Accelerator

SparkLabs Cultiv8 launches CleanTech Accelerator

...

77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting

77.4% ORR! Abbisko to present the updated clinical phase Ib data of Pimicotinib (ABSK021) at the 2023 ASCO Annual Meeting

...

Credits roll on two weeks of unforgettable creations inspired by Campari, at 76th Festival de Cannes

Credits roll on two weeks of unforgettable creations inspired by Campari, at 76th Festival de Cannes

...

menu
menu